Contact

All Stories

  1. Chest X‐Ray Interpretation in the EPICO Pediatric COVID‐19 Study: Addressing Misconceptions

    Article • Pediatric Pulmonology, September 2025, Wiley

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  2. Renaming the tropical febrile syndrome: A clinical and semantic imperative in global health

    Article • Travel Medicine and Infectious Disease, September 2025, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  3. Correction: Long COVID clinical evaluation, research and impact on society: a global expert consensus

    Article • Annals of Clinical Microbiology and Antimicrobials, July 2025, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  4. Mpox: Characterization and clinical outcomes of patients in Colombian healthcare institutions

    Article • Global Epidemiology, June 2025, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  5. Infectious diseases prevention and vaccination in migrants in Latin America: The challenges of transit through the treacherous Darien gap, Panama

    Article • Travel Medicine and Infectious Disease, May 2025, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  6. Key success factors in clinical trial operation of the smallpox vaccine LC16m8 against mpox in Colombia

    Article • Global Health & Medicine, April 2025, National Center for Global Health and Medicine (JST)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  7. Corrigendum: Phenotypic Variation in Disease Severity Among Hospitalized Pediatric Patients With COVID-19: Assessing the Impact of COVID-19 in the EPICO Study

    Article • International Journal of Public Health, April 2025, Frontiers

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  8. Phenotypic Variation in Disease Severity Among Hospitalized Pediatric Patients With COVID-19: Assessing the Impact of COVID-19 in the EPICO Study

    Article • International Journal of Public Health, March 2025, Frontiers

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  9. Evidence-based clinical standard for the diagnosis and treatment of invasive lung aspergillosis in the patient with oncohematologic disease

    Article • The Brazilian Journal of Infectious Diseases, March 2025, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  10. Multiplex PCR Pneumonia Panel in Critically Ill Patients Did Not Modify Mortality: A Cohort Study

    Article • Antibiotics, February 2025, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  11. What to Look for in Chest X‐Rays of Pediatric Patients With COVID‐19: Insights From a Colombian Cohort

    Article • Pediatric Pulmonology, February 2025, Wiley

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  12. Uveítis infecciosa: epidemiología, etiología, rendimiento de pruebas diagnósticas y tratamiento

    Article • Archivos de la Sociedad Española de Oftalmología, February 2025, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  13. Evidence-based clinical standard for the diagnosis and treatment of candidemia in critically ill patients in the intensive care unit

    Article • The Brazilian Journal of Infectious Diseases, January 2025, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  14. Management and efficiency in highly complex public healthcare: an analysis of financial ratios and non-parametric statistic

    Article • Data & Metadata, December 2024, Salud, Ciencia y Tecnologia

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  15. Development of a diagnostic multivariable prediction model of a positive SARS-CoV-2 RT-PCR result in healthcare workers with suspected SARS-CoV-2 infection in hospital settings

    Article • PLOS One, December 2024, PLOS

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  16. Interplay of Transcriptomic Regulation, Microbiota, and Signaling Pathways in Lung and Gut Inflammation-Induced Tumorigenesis

    Article • Cells, December 2024, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  17. Predictive modelling of the effectiveness of vaccines against COVID-19 in Bogotá: Methodological innovation involving different variants and computational optimisation efficiency

    Article • Heliyon, November 2024, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  18. ¿Cómo prepararnos para una futura pandemia?

    Article • Infectio, September 2024, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  19. Global transcriptomic network analysis of the crosstalk between microbiota and cancer-related cells in the oral-gut-lung axis

    Article • Frontiers in Cellular and Infection Microbiology, August 2024, Frontiers

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  20. The Effectiveness of Generic Piperacillin/Tazobactam in Managing Gram-Negative Bacillary Bacteremia in Adult Patients at a Tertiary Care Hospital

    Article • June 2024, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  21. Guía de práctica clínica para el diagnóstico y tratamiento de la histoplasmosis en personas adultas que viven con el VIH – versión corta

    Article • Infectio, May 2024, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  22. Efficacy of Continuous vs. Intermittent Administration of Cefepime in Adult ICU Patients with Gram-Negative Bacilli Bacteremia: A Randomized Double-Blind Clinical Study

    Article • Antibiotics, February 2024, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  23. Financiación pública de los sistemas de Ciencia e Innovación en Latinoamérica: Una herramienta esencial para mejorar la prevención y la atención en salud

    Article • Infectio, February 2024, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  24. Guía de práctica clínica para el diagnóstico y tratamiento de la criptococosis en personas adultas que viven con el VIH

    Article • Infectio, February 2024, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  25. Differential Diagnosis in the Management of Acute Respiratory Infections through Point-of-Care Rapid Testing in a Post-Pandemic Scenario in Latin America: Special Focus on COVID-19, Influenza, and Respiratory Syncytial Virus

    Article • COVID, February 2024, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  26. Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review

    Article • Systematic Reviews, January 2024, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  27. Efficacy of Continuous vs. Intermittent Administration of Cefepime in Adult ICU Patients with Gram‐Negative Bacilli Bacteremia: A Randomized Double‐Blind Clinical Study

    Article • January 2024, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  28. Challenges and opportunities in the face of Mpox in Latin America

    Article • Therapeutic Advances in Infectious Disease, January 2024, SAGE Publications

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  29. Mpox: Characterization and Clinical Outcomes of Patients in Colombian Healthcare Institutions

    Article • January 2024, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  30. Mpox: Characterization and Clinical Outcomes of Patients in Colombian Healthcare Institutions

    Article • January 2024, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  31. Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis

    Article • International Journal of Molecular Sciences, November 2023, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  32. Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry

    Article • Nefrología, November 2023, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  33. SARS-CoV-2 vaccination strategies: Should the extended dosing interval strategy be implemented in future pandemics?

    Article • Travel Medicine and Infectious Disease, November 2023, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  34. Multinational prospective cohort study of incidence and risk factors for central line-associated bloodstream infections in ICUs of 8 Latin American countries

    Article • American Journal of Infection Control, October 2023, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  35. Bacteremia by non-O1/non-O139 Vibrio cholerae: Case description and literature review

    Article • Biomédica, September 2023, Instituto Nacional de Salud

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  36. Long COVID in low-income and middle-income countries: the hidden public health crisis

    Article • The Lancet, September 2023, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  37. Reasons for antiretroviral switching in Colombia: A retrospective cohort study

    Article • International Journal of STD & AIDS, July 2023, SAGE Publications

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  38. The global challenges of the long COVID-19 in adults and children

    Article • Travel Medicine and Infectious Disease, July 2023, Elsevier

    Andre Megarbane, Toufic Chaaban, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  39. Mortality Caused by Candida auris Bloodstream Infections in Comparison with Other Candida Species, a Multicentre Retrospective Cohort

    Article • Journal of Fungi, June 2023, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  40. Interventions to Improve Antibiotic Use in Hospitals with Different Levels of Complexity in Colombia: Findings from a Before-and-After Study and Suggestions for the Future

    Article • Antibiotics, May 2023, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  41. Associated factors for mortality in a COVID-19 colombian cohort: is the third wave relevant when Mu variant was predominant epidemiologically?

    Article • Travel Medicine and Infectious Disease, May 2023, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  42. Clinical and epidemiological characteristics of mpox: A descriptive cases series in Colombia

    Article • Travel Medicine and Infectious Disease, May 2023, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  43. Viral reactivations and co-infections in COVID-19 patients: a systematic review

    Article • BMC Infectious Diseases, April 2023, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  44. Guía de práctica clínica colombiana para el tratamiento de infecciones bacterianas de piel y tejidos blandos superficiales en Población pediátrica

    Article • Infectio, April 2023, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  45. Consenso de expertos para el tratamiento antimicrobiano de las infecciones causadas por bacilos gram negativos multirresistentes en pacientes adultos

    Article • Infectio, April 2023, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  46. Multinational prospective cohort study over 24 years of the risk factors for ventilator-associated pneumonia in 187 ICUs in 12 Latin American countries: Findings of INICC

    Article • Journal of Critical Care, April 2023, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  47. The Mortality Attributable to Candidemia in C. auris Is Higher than That in Other Candida Species: Myth or Reality?

    Article • Journal of Fungi, March 2023, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  48. Fungemia in Hospitalized Adult Patients with Hematological Malignancies: Epidemiology and Risk Factors

    Article • Journal of Fungi, March 2023, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  49. Comment on: Gaps and barriers in the implementation and functioning of antimicrobial stewardship programmes: results from an educational and behavioural mixed methods needs assessment in France, the United States, Mexico and India

    Article • JAC-Antimicrobial Resistance, March 2023, Oxford University Press (OUP)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  50. Molecular and Clinical Data of Antimicrobial Resistance in Microorganisms Producing Bacteremia in a Multicentric Cohort of Patients with Cancer in a Latin American Country

    Article • Microorganisms, January 2023, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  51. Adenovirus Respiratory Infections Post Pandemic in Colombia

    Article • The Pediatric Infectious Disease Journal, January 2023, Wolters Kluwer Health

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  52. Long COVID-19 in Latin America: Low prevalence, high resilience or low surveillance and difficulties accessing health care?

    Article • Travel Medicine and Infectious Disease, January 2023, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  53. Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry

    Article • Nefrología (English Edition), January 2023, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  54. Associated Factors for Mortality in a COVID-19 Colombian Cohort by Epidemic Wave: Is the Predominance of Mu Variant Relevant?

    Article • January 2023, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  55. Clinical and Epidemiological Characteristics of Mpox: A Descriptive Cases Series in Colombia

    Article • January 2023, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  56. Metformin Use Is Associated With Lower Mortality in Veterans With Diabetes Hospitalized With Pneumonia

    Article • Clinical Infectious Diseases, December 2022, Oxford University Press (OUP)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  57. Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic

    Article • Expert Review of Vaccines, November 2022, Taylor & Francis

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  58. The Risk and Clinical Implications of Antibiotic-Associated Acute Kidney Injury: A Review of the Clinical Data for Agents with Signals from the Food and Drug Administration’s Adverse Event Reporting System (FAERS) Database

    Article • Antibiotics, October 2022, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  59. Multinational Prospective Cohort Study of Mortality Risk Factors in 198 ICUs of 12 Latin American Countries over 24 Years: The Effects of Healthcare-Associated Infections

    Article • October 2022, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  60. Association of medical tests use with care continuity in primary care service: evidence from the Department of Veterans Affairs

    Article • Family Practice, September 2022, Oxford University Press (OUP)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  61. Expert Review of Global Real-World Data on COVID-19 Vaccine Booster Effectiveness & Safety During the Omicron-dominant Phase of the Pandemic

    Article • September 2022, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  62. Further implications on the global real-world vaccine effectiveness against SARS-CoV-2

    Article • Expert Review of Vaccines, August 2022, Taylor & Francis

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  63. Section 2. Colombian consensus for prophylaxis, treatment and prevention of invasive aspergillosis in adult and pediatric patients

    Article • Infectio, July 2022, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  64. Section 3. Colombian consensus on the diagnosis and treatment of extrapulmonary aspergillosis in adult patients

    Article • Infectio, July 2022, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  65. Section 4. Colombian consensus on the diagnosis and treatment of chronic, saprophytic and/or allergic syndromes associated with Aspergillus spp. in adult and pediatric patients

    Article • Infectio, July 2022, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  66. Section 1. Colombian consensus on the diagnosis and follow-up of invasive aspergillosis and Aspergillus disease in adult and pediatric patients

    Article • Infectio, July 2022, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  67. Guía de práctica clínica para la Profilaxis quirúrgica antimicrobiana

    Article • Infectio, July 2022, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  68. The environment also molds microbes in our respiratory airways that are important for our health

    Article • June 2022, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Maria Mercedes Zambrano

  69. Impact of SARS-CoV-2 vaccination in healthcare workers in a network of clinics in Latin America

    Article • IJID Regions, June 2022, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  70. Cardiovascular risk factors and comorbidities in people living with HIV: A cross-sectional multicenter study from Colombia comorbidities in a Colombian PLWHIV population

    Article • International Journal of STD & AIDS, May 2022, SAGE Publications

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  71. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses

    Article • The Lancet, May 2022, Elsevier

    MD, PhD ANTONIO PORTOLES, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Prof. Dr. Abdullah M. Asiri

  72. An Operations Approach for Reducing Glycemic Variability: Evidence from a Primary Care Setting

    Article • Manufacturing & Service Operations Management, May 2022, INFORMS

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  73. A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): A consensus of Latin American experts

    Article • International Journal of Infectious Diseases, April 2022, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  74. Strengthening a Study of Diabetes Progression After Statin Use—Reply

    Article • JAMA Internal Medicine, April 2022, American Medical Association (AMA)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  75. The Risk of Clostridioides difficile Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts

    Article • Antibiotics, February 2022, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  76. Head-to-head comparison of CLSI, EUCAST, Etest and Vitek2 results for Candida auris susceptibility testing

    Article • International Journal of Antimicrobial Agents, February 2022, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  77. Impact of TR34/L98H, TR46/Y121F/T289A and TR53 Alterations in Azole-Resistant Aspergillus fumigatus on Sterol Composition and Modifications after In Vitro Exposure to Itraconazole and Voriconazole

    Article • Microorganisms, January 2022, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  78. Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial

    Article • EClinicalMedicine, January 2022, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  79. Associated Factors for Mortality in a COVID-19 Colombian Cohort by Epidemic Wave: Is the Predominance of Mu Variant Relevant?

    Article • SSRN Electronic Journal, January 2022, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  80. Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistantCandida glabrata

    Article • Journal of Antimicrobial Chemotherapy, December 2021, Oxford University Press (OUP)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  81. Guía de práctica clínica para el manejo de la neumonía adquirida en la comunidad

    Article • Revista de la Facultad de Medicina, December 2021, Universidad Nacional de Colombia

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  82. Long-term consequences of the misuse of ivermectin data

    Article • The Lancet Infectious Diseases, December 2021, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  83. Association of Statin Therapy Initiation With Diabetes Progression

    Article • JAMA Internal Medicine, December 2021, American Medical Association (AMA)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  84. Enhancing Regulatory Decision Making for Postmarket Drug Safety

    Article • Management Science, December 2021, INFORMS

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  85. Effectiveness of Beta-Lactam plus Doxycycline for Patients Hospitalized with Community-Acquired Pneumonia

    Article • Clinical Infectious Diseases, November 2021, Oxford University Press (OUP)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  86. Colombian HIV/AIDS registry and health risk management

    Article • Infectio, October 2021, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  87. Understanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: A Modelling Analysis

    Article • Clinical Infectious Diseases, September 2021, Oxford University Press (OUP)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  88. Effectiveness of Rosuvastatin plus Colchicine, Emtricitabine/Tenofovir and a combination of them in Hospitalized Patients with SARS Covid-19

    Article • July 2021, Cold Spring Harbor Laboratory Press

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  89. Understanding the Potential Impact of Different Drug Properties On SARS-CoV-2 Transmission and Disease Burden: A Modelling Analysis

    Article • June 2021, Cold Spring Harbor Laboratory Press

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  90. Manifestaciones radiológicas de la melioidosis pulmonar. Serie de casos

    Article • Radiología, May 2021, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  91. SECCION I. Antecedentes de infección por SARS-CoV-2/COVID-19

    Article • Infectio, April 2021, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  92. Clinical course, biomarkers, management and outcomes of patients hospitalised due to COVID-19 in Colombia

    Article • Infectio, April 2021, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  93. Consensus Recommendations Based on Evidence for Abdominal Sepsis in the Pediatric and Adult Population of Colombia

    Article • Infectio, April 2021, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  94. Implications of Antibiotic Use during the COVID-19 Pandemic: The Example of Associated Antimicrobial Resistance in Latin America

    Article • Antibiotics, March 2021, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  95. Socioeconomic inequalities associated with mortality for COVID-19 in Colombia: a cohort nationwide study

    Article • Journal of Epidemiology & Community Health, March 2021, BMJ

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  96. Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1–5

    Article • Hypertension, March 2021, Wolters Kluwer Health

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  97. Guía de práctica clínica para la tamización de pacientes con riesgo de colonización por Enterobacterales productores de carbapenemasas y el manejo de infecciones causadas por estas bacterias

    Article • Revista de la Facultad de Medicina, March 2021, Universidad Nacional de Colombia

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  98. Do the types and routes of proton pump inhibitor treatments affect clostridium difficile in ICU patients? A retrospective cohort study

    Article • Expert Review of Clinical Pharmacology, February 2021, Taylor & Francis

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  99. Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, February 2021, New England Journal of Medicine (NEJM/MMS)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, MD, PhD ANTONIO PORTOLES, Prof. Dr. Abdullah M. Asiri

  100. Experience of clinical screening for COVID-19 among patients undergoing elective orthopedic surgeries: an alternative proposal

    Article • Journal of Orthopaedic Surgery and Research, February 2021, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  101. Real-World Use of Generic Meropenem: Results of an Observational Study

    Article • Antibiotics, January 2021, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  102. Prevalence and Significance of Potential Pharmacokinetic Drug–Drug Interactions Among Patients with Lung Cancer: Implications for Clinical Trials

    Article • Clinical Drug Investigation, January 2021, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  103. Burden and magnitude of risk in HIV/AIDS in the Colombian health system: a real-world data approach

    Article • Infectio, January 2021, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  104. Socioeconomic inequalities associated with mortality for COVID-19 in Colombia: A cohort nation-wide study

    Article • December 2020, Cold Spring Harbor Laboratory Press

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  105. <p>Acetylcholine Regulates Pulmonary Pathology During Viral Infection and Recovery</p>

    Article • ImmunoTargets and Therapy, December 2020, Taylor & Francis

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  106. Real-World Effectiveness of Meropenem: Results of an Observational Study in 84 Colombian Patients

    Article • November 2020, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  107. Citoquinas pro y anti-inflamatorias en la infección por SARS-CoV-2, en población de Colombia

    Article • Infectio, November 2020, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  108. Case Report: Gestational Melioidosis through Perinatal Transmission

    Article • American Journal of Tropical Medicine and Hygiene, November 2020, American Society of Tropical Medicine and Hygiene

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  109. A One Health Perspective to Recognize Fusarium as Important in Clinical Practice

    Article • Journal of Fungi, October 2020, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  110. Candida auris: A Latent Threat to Critically Ill Patients With Coronavirus Disease 2019

    Article • Clinical Infectious Diseases, October 2020, Oxford University Press (OUP)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  111. A One Health Perspective to Recognize Fusarium and Neocosmospora as Important in Clinical Practice

    Article • September 2020, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  112. Una hoja de ruta para la Vacuna COVID 19 en Colombia, un reto posible

    Article • Infectio, September 2020, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Professor Manuel Alfonso Patarroyo

  113. Maintaining Continuity in Service: An Empirical Examination of Primary Care Physicians

    Article • Manufacturing & Service Operations Management, September 2020, INFORMS

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  114. Lactic acidosis incidence with metformin in patients with type 2 diabetes and chronic kidney disease: A retrospective nested case‐control study

    Article • Endocrinology Diabetes & Metabolism, July 2020, Wiley

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  115. Correction to: Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)

    Article • Drug Safety, June 2020, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  116. 1596-P: Evaluating Reports of Pancreatic Malignancy and Liraglutide: A Pharmacovigilance Study of the FDA Adverse Event Reporting System

    Article • Diabetes, June 2020, American Diabetes Association

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  117. Toward to establish selection criteria for rapid serological tests for COVID-19

    Article • Infectio, May 2020, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  118. Volver a empezar: cirugía electiva durante la pandemia del SARS-CoV2. Recomendaciones desde la Asociación Colombiana de Cirugía

    Article • Revista Colombiana de Cirugía, May 2020, Asociacion Colombiana de Cirugia

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  119. Testing Dilemmas: Post negative, positive SARS-CoV-2 RT-PCR – is it a reinfection?

    Article • Travel Medicine and Infectious Disease, May 2020, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  120. A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19)

    Article • Infectio, April 2020, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  121. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia

    Article • Infectio, March 2020, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  122. Temporal Factors Associated With Opioid Prescriptions for Patients With Pain Conditions in an Urban Emergency Department

    Article • JAMA Network Open, March 2020, American Medical Association (AMA)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  123. Rates of appropriate laxative prophylaxis for opioid-induced constipation in veterans with lung cancer: a retrospective cohort study

    Article • Supportive Care in Cancer, March 2020, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  124. Evaluation of Vitamin B12 Monitoring in Veterans With Type 2 Diabetes on Metformin Therapy

    Article • Journal of Pharmacy Practice, January 2020, SAGE Publications

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  125. Persistence of clonal azole-resistant isolates of Candida albicans from a patient with chronic mucocutaneous candidiasis in Colombia

    Article • Journal of Global Infectious Diseases, January 2020, Medknow

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  126. QTc Interval-Prolonging Medications Among Patients With Lung Cancer: Implications for Clinical Trial Eligibility and Clinical Care

    Article • Clinical Lung Cancer, January 2020, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  127. Impact of a Formulation Containing Unusual Polyunsaturated Fatty Acids, Trace Elements, Polyphenols and Plant Sterols on Insulin Resistance and Associated Disturbances

    Article • Diabetes Therapy, November 2019, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  128. Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)

    Article • Drug Safety, October 2019, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  129. Association of atypical antipsychotics and mortality for patients hospitalised with pneumonia

    Article • ERJ Open Research, October 2019, European Respiratory Society (ERS)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  130. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module

    Article • American Journal of Infection Control, October 2019, Elsevier

    Assoc. Prof. Horhat Florin George, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Professor Hakan Erdem, Dr Shakti B Mishra, S Vadi, Dr Gabriel Arteaga-Troncoso

  131. Risk factors associated with methicillin-resistant Staphylococcus aureus skin and soft tissue infections in hospitalized patients in Colombia

    Article • International Journal of Infectious Diseases, October 2019, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  132. Statin use and medically attended acute respiratory illness among influenza vaccine recipients

    Article • Vaccine, October 2019, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  133. Guía de práctica clínica para el diagnóstico y manejo de las infecciones de piel y tejidos blandos en Colombia

    Article • Infectio, September 2019, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  134. Clinical practice guidelines: An Opportunity to provide health care with excellence and the new Colombian Guidelines for the diagnosis and management of Skin and Soft tissue infections (SSTIs)

    Article • Infectio, September 2019, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  135. Case Series Study of Melioidosis, Colombia

    Article • Emerging Infectious Diseases, August 2019, Centers for Disease Control and Prevention (CDC)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  136. Risk of invasive fungal infections during hospital construction

    Article • Current Opinion in Infectious Diseases, August 2019, Wolters Kluwer Health

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  137. A cohort study of two intravenous treatments for iron deficiency in patients with heart failure

    Article • Acta Cardiologica, July 2019, Taylor & Francis

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  138. Abstract 3368: Prevalence and significance of drug-drug interactions among patients with lung cancer

    Article • Cancer Research, July 2019, American Association for Cancer Research (AACR)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  139. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study

    Article • The Lancet Infectious Diseases, June 2019, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Souha Kanj

  140. Comparison between MALDI-TOF MS and MicroScan in the identification of emerging and multidrug resistant yeasts in a fourth-level hospital in Bogotá, Colombia

    Article • BMC Microbiology, May 2019, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  141. The cost of hospital care for HIV patients in Colombia: an insurer’s perspective

    Article • International Journal of STD & AIDS, May 2019, SAGE Publications

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  142. Melioidosis en Colombia, descripción de un caso clínico y consideraciones epidemiológicas

    Article • Biomédica, May 2019, Instituto Nacional de Salud

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  143. First case of Aspergillus caelatus airway colonization in a Chronic Obstructive Pulmonary Disease patient

    Article • International Journal of Infectious Diseases, April 2019, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  144. Antifungal stewardship: consensus on the diagnosis, treatment, and prevention of Candida spp. disease is a fundamental step in the road map to achieve it

    Article • Infectio, March 2019, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  145. Colombian consensus on the diagnosis, treatment, and prevention of Candida Spp. disease in children and adults*,+

    Article • Infectio, March 2019, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  146. Fungicide-driven alterations in azole-resistant Aspergillus fumigatus are related to vegetable crops in Colombia, South America

    Article • Mycologia, March 2019, Taylor & Francis

    Dr Jacques F Meis, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  147. Evaluación y manejo del riesgo cardiovascular en infección por VIH. Consenso de expertos ACIN

    Article • Infectio, November 2018, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  148. Paracoccidioidomycosis simulating Crohn’s disease

    Article • International Journal of Infectious Diseases, July 2018, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  149. Necrotizing fasciitis caused by Apophysomyces variabilis in an immunocompetent patient

    Article • Medical Mycology Case Reports, June 2018, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  150. Association of Statin Use with Increased Risk of Musculoskeletal Conditions: A Retrospective Cohort Study

    Article • Drug Safety, May 2018, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  151. Use of QTc-prolonging medications among patients with lung cancer: implications for clinical trials and standard clinical care.

    Article • Journal of Clinical Oncology, May 2018, American Society of Clinical Oncology (ASCO)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  152. Impact of total body weight on acute kidney injury in patients with gram-negative bacteremia

    Article • Expert Review of Clinical Pharmacology, May 2018, Taylor & Francis

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  153. Opciones terapéuticas frente a especies de Candida resistentes a las equinocandinas

    Article • Universitas Médica, April 2018, Editorial Pontificia Universidad Javeriana

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  154. Polypharmacy and patterns of prescription medication use among cancer survivors

    Article • Cancer, April 2018, Wiley

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  155. First report of sporadic cases of Candida auris in Colombia

    Article • International Journal of Infectious Diseases, April 2018, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  156. Burden of Fungal Infections in Colombia

    Article • Journal of Fungi, March 2018, MDPI AG

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  157. What has been researched about MDR- Candida auris ? A bibliometric analysis on the ‘new kid on the block’ in hospital-associated infections

    Article • Journal of Infection and Public Health, March 2018, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  158. Erratum for Arias et al., “A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries”

    Article • Antimicrobial Agents and Chemotherapy, February 2018, ASM Journals

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  159. Association of Statin Therapy With Risk of Epilepsy in 2 Propensity Score–Matched Cohorts

    Article • Annals of Pharmacotherapy, February 2018, SAGE Publications

    Dr Ishak A Mansi, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  160. Diagnosis and treatment of latent tuberculosis in patients with multiple sclerosis, expert consensus. On behalf of the Colombian Association of Neurology, Committee of Multiple Sclerosis

    Article • Multiple Sclerosis Journal - Experimental Translational and Clinical, January 2018, SAGE Publications

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  161. Usefulness of thick blood smears in the diagnosis of disseminated histoplasmosis

    Article • International Journal of Infectious Diseases, December 2017, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  162. Practical Recommendations for Preoperative Skin Antisepsis

    Article • Infectio, November 2017, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  163. Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study

    Article • Journal of Antimicrobial Chemotherapy, October 2017, Oxford University Press (OUP)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  164. Metformin Safety Warnings and Diabetes Drug Prescribing Patterns for Older Nursing Home Residents

    Article • Journal of the American Medical Directors Association, October 2017, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  165. A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries

    Article • Antimicrobial Agents and Chemotherapy, July 2017, ASM Journals

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  166. Association of Statin Use With Risk of Back Disorder Diagnoses

    Article • JAMA Internal Medicine, July 2017, American Medical Association (AMA)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  167. Tigeciclina en infecciones de piel y tejidos blandos complicadas.

    Article • Infectio, June 2017, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  168. First Colombian consensus on congenital Chagas and clinical approach for women of child-bearing age diagnosed with Chagas

    Article • Infectio, June 2017, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  169. Tigeciclina en infecciones intraabdominales complicadas

    Article • Infectio, June 2017, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  170. Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis in Latin America Compared With the Rest of the World Population

    Article • JCR Journal of Clinical Rheumatology, June 2017, Wolters Kluwer Health

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  171. High Initiation of Adjuvant Hormonal Therapy Among Uninsured Stages I–III Breast Cancer Patients Treated in a Safety-Net Healthcare System

    Article • Journal of Women s Health, June 2017, Mary Ann Liebert Inc

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  172. Impact of total body weight on 30-day mortality in patients with gram-negative bacteremia

    Article • Expert Review of Anti-infective Therapy, May 2017, Taylor & Francis

    Ronald Hall, Andrew Faust, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  173. Lingual tuberculosis in an HIV/AIDS patient

    Article • International Journal of Infectious Diseases, May 2017, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  174. Azole-resistant Aspergillus fumigatus harboring TR34/L98H, TR46/Y121F/T289A and TR53 mutations related to flower fields in Colombia

    Article • Scientific Reports, March 2017, Springer Science + Business Media

    Dr Jacques F Meis, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  175. Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia

    Article • Emerging Infectious Diseases, January 2017, Centers for Disease Control and Prevention (CDC)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  176. Low–health literacy flashcards & mobile video reinforcement to improve medication adherence in patients on oral diabetes, heart failure, and hypertension medications

    Article • Journal of the American Pharmacists Association, January 2017, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  177. International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module

    Article • American Journal of Infection Control, December 2016, Elsevier

    Assoc. Prof. Horhat Florin George, Dr Gabriel Arteaga-Troncoso, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Dr Shakti B Mishra, PhD Fernando Martín Guerra Infante, Souha Kanj

  178. Identification of cryptic Candida species by MALDI-TOF mass spectrometry, not all MALDI-TOF systems are the same: focus on the C. parapsilosis species complex

    Article • Diagnostic Microbiology and Infectious Disease, December 2016, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  179. Risk factors for methicillin-resistant Staphylococcus aureus bacteremia: A multicenter matched case-control study

    Article • Biomédica, December 2016, Instituto Nacional de Salud

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  180. Multicenter study in Colombia: Impact of a multidimensional International Nosocomial Infection Control Consortium (INICC) approach on central line–associated bloodstream infection rates

    Article • American Journal of Infection Control, November 2016, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  181. Consenso colombiano para la estratificación, diagnóstico, tratamiento y prevención de la infección por citomegalovirus en pacientes adultos con trasplante renal

    Article • Infectio, October 2016, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  182. Impact of an Analgesia-Based Sedation Protocol on Mechanically Ventilated Patients in a Medical Intensive Care Unit

    Article • Anesthesia & Analgesia, October 2016, Wolters Kluwer Health

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  183. Saksenaea erythrospora infection after medical tourism for esthetic breast augmentation surgery

    Article • International Journal of Infectious Diseases, August 2016, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  184. Virus de hepatitis B y C. Retos en su tratamiento

    Article • Infectio, July 2016, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  185. Pérdida de seguimiento y factores asociados en pacientes inscritos en el programa de HIV/sida del Hospital Universitario San Ignacio, Colombia, 2012-2013

    Article • Biomédica, May 2016, Instituto Nacional de Salud

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  186. Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries

    Article • PLOS One, April 2016, PLOS

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  187. Abstract C59: Initiation of adjuvant hormonal therapy among uninsured stage I-III breast cancer patients treated in a safety-net healthcare system

    Article • Cancer Epidemiology Biomarkers & Prevention, March 2016, American Association for Cancer Research (AACR)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  188. Factores de riesgo para bacteriemia adquirida en el hospital por Pseudomonas aeruginosa resistente a carbapenémicos en un hospital colombiano

    Article • Biomédica, February 2016, Instituto Nacional de Salud

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  189. Challenges with Diagnosing and Managing Sepsis in Older Adults

    Article • Expert Review of Anti-infective Therapy, January 2016, Taylor & Francis

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  190. Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial

    Article • PLOS One, January 2016, PLOS

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  191. Multiple Fungicide-Driven Alterations in Azole-ResistantAspergillus fumigatus, Colombia, 2015

    Article • Emerging Infectious Diseases, January 2016, Centers for Disease Control and Prevention (CDC)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  192. Risk Factors Associated With Methicillin-Resistant Staphylococcus aureus (MRSA) Complicated Skin and Soft Tissue Infection in Colombia

    Article • Open Forum Infectious Diseases, January 2016, Oxford University Press (OUP)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  193. Guía de práctica clínica sobre diagnóstico y tratamiento de infección de vías urinarias no complicada en mujeres adquirida en la comunidad

    Article • Revista de la Facultad de Medicina, December 2015, Universidad Nacional de Colombia

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  194. Safety Profile of Nifurtimox and Treatment Interruption for Chronic Chagas Disease in Colombian Adults

    Article • American Journal of Tropical Medicine and Hygiene, December 2015, American Society of Tropical Medicine and Hygiene

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  195. Methicillin-Resistant Staphylococcus aureus USA300 Latin American Variant in Patients Undergoing Hemodialysis and HIV Infected in a Hospital in Bogotá, Colombia

    Article • PLOS One, October 2015, PLOS

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  196. Exposure to High-Risk Medications is Associated With Worse Outcomes in Older Veterans With Chronic Pain

    Article • The American Journal of the Medical Sciences, October 2015, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  197. Frecuencia de colonización de staphylococcus aureus meticilino - resistente, de enterobacterias y de candida spp. en estetoscopios y teléfonos móviles en una unidad de cuidados intensivos neonatal

    Article • Revista Salud Bosque, August 2015, Universidad el Bosque

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  198. Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications

    Article • Clinical Pharmacology & Therapeutics, July 2015, Wiley

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  199. Sodium-glucose co-transporter inhibition in the treatment of diabetes: Sweetening the pot

    Article • Diabetes and Vascular Disease Research, February 2015, SAGE Publications

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  200. State-of-the-Art: Hypo-responsiveness to Oral Antiplatelet Therapy in Patients with Type 2 Diabetes Mellitus

    Article • Current Cardiovascular Risk Reports, January 2015, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  201. Association of skeletal muscle relaxers and antihistamines on mortality, hospitalizations, and emergency department visits in elderly patients: a nationwide retrospective cohort study

    Article • BMC Geriatrics, January 2015, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  202. Multicenter Study of Skin and Soft Tissue Infections Complicated in Hospitalized Patients 2009–2014 in Colombia

    Article • Open Forum Infectious Diseases, January 2015, Oxford University Press (OUP)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  203. Empiric Weight-Based Vancomycin in Intensive Care Unit Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia

    Article • The American Journal of the Medical Sciences, November 2014, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  204. Costo-efectividad de linezolid comparado con vancomicina en el manejo de la neumonía asociada a ventilación mecánica en Colombia

    Article • Infectio, October 2014, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  205. Surgical site infection rates in 4 cities in Colombia: Findings of the International Nosocomial Infection Control Consortium (INICC)

    Article • American Journal of Infection Control, October 2014, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  206. Azithromycin for Elderly Patients With Pneumonia—Reply

    Article • JAMA, October 2014, American Medical Association (AMA)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  207. Impact of empiric weight-based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin-resistantStaphylococcus aureusbacteraemia

    Article • Journal of Clinical Pharmacy and Therapeutics, September 2014, Wiley

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  208. International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

    Article • American Journal of Infection Control, September 2014, Elsevier

    Dr Gabriel Arteaga-Troncoso, Professor Hakan Leblebicioglu, Assoc. Prof. Horhat Florin George, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Dr Evangelos I. Kritsotakis, Professor Hakan Erdem, PhD Fernando Martín Guerra Infante, Souha Kanj, Prof. Dr. Abdullah M. Asiri

  209. Gram-negative infections in pediatric and neonatal intensive care units of Latin America

    Article • The Journal of Infection in Developing Countries, August 2014, Journal of Infection in Developing Countries

    Dr Mauro Jose Costa Salles, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  210. Efficacy of Three Different Regimens of Primaquine for the Prevention of Relapses of Plasmodium vivax Malaria in the Amazon Basin of Peru

    Article • American Journal of Tropical Medicine and Hygiene, July 2014, American Society of Tropical Medicine and Hygiene

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  211. Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America

    Article • The Brazilian Journal of Infectious Diseases, July 2014, Elsevier

    Dr Mauro Jose Costa Salles, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  212. Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia

    Article • JAMA, June 2014, American Medical Association (AMA)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  213. Primer consenso colombiano sobre Chagas congénito y orientación clínica a mujeres en edad fértil con diagnóstico de Chagas

    Article • Infectio, April 2014, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  214. Impacto económico de la resistencia a meticilina en pacientes con bacteriemia por Staphylococcus aureus en hospitales de Bogotá

    Article • Biomédica, March 2014, Instituto Nacional de Salud

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  215. Diseminación de Klebsiella pneumoniae productoras de KPC-3 en hospitales de Bogotá durante un periodo de tres años

    Article • Biomédica, January 2014, Instituto Nacional de Salud

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  216. 155Implementation of a national surveillance program for antimicrobial use, Colombia 2012-2013

    Article • Open Forum Infectious Diseases, January 2014, Oxford University Press (OUP)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  217. Evolución de la resistencia antimicrobiana de bacilos Gram negativos en unidades de cuidados intensivos en Colombia

    Article • Biomédica, November 2013, Instituto Nacional de Salud

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  218. Efecto del tratamiento antibiótico inicial adecuado sobre la mortalidad en pacientes en estado crítico con bacteriemia por Pseudomonas aeruginosa

    Article • Biomédica, September 2013, Instituto Nacional de Salud

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  219. Molecular epidemiology and characterization of virulence genes of community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus isolates in Colombia

    Article • International Journal of Infectious Diseases, September 2013, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  220. Resistant Gram-negative infections in the outpatient setting in Latin America

    Article • Epidemiology and Infection, August 2013, Cambridge University Press

    Dr Mauro Jose Costa Salles, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  221. Surgical Site Infections, International Nosocomial Infection Control Consortium (INICC) Report, Data Summary of 30 Countries, 2005–2010

    Article • Infection Control, June 2013, Cambridge University Press

    Dr Gabriel Arteaga-Troncoso, Professor Hakan Leblebicioglu, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Souha Kanj

  222. The Quality of Quality Measures: HEDIS® Quality Measures for Medication Management in the Elderly and Outcomes Associated with New Exposure

    Article • Drugs & Aging, May 2013, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  223. Emergencia de fenotipos resistentes a cefalosporinas de tercera generación en Enterobacteriaceae causantes de infección del tracto urinario de inicio comunitario en hospitales de Colombia

    Article • Enfermedades Infecciosas y Microbiología Clínica, May 2013, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  224. Frequency of microorganisms isolated in patients with bacteremia in intensive care units in Colombia and their resistance profiles

    Article • The Brazilian Journal of Infectious Diseases, May 2013, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  225. Predicting out of intensive care unit cardiopulmonary arrest or death using electronic medical record data

    Article • BMC Medical Informatics and Decision Making, February 2013, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  226. Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study

    Article • BMC Pharmacology and Toxicology, February 2013, Springer Science + Business Media

    Ronald Hall, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  227. Consenso colombiano de neumonía nosocomial 2013

    Article • Infectio, January 2013, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  228. Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in adult intensive care units from 14 developing countries of four continents

    Article • Critical Care Medicine, December 2012, Wolters Kluwer Health

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Souha Kanj

  229. Utilidad clínica de la detección antigénica de galactomanano en el diagnóstico de aspergilosis invasora en un hospital universitario de tercer nivel en Bogotá (Colombia) 2010–2012

    Article • Infectio, December 2012, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  230. Mortality among critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia: a multicenter cohort study in Colombia

    Article • Revista Panamericana de Salud Pública, November 2012, FapUNIFESP (SciELO)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  231. Sustained Efficacy and Safety of Raltegravir After 5 Years of Combination Antiretroviral Therapy as Initial Treatment of HIV-1 Infection

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, September 2012, Wolters Kluwer Health

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  232. Effectiveness of a multidimensional approach to reduce ventilator-associated pneumonia in pediatric intensive care units of 5 developing countries: International Nosocomial Infection Control Consortium findings

    Article • American Journal of Infection Control, August 2012, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  233. Findings of the International Nosocomial Infection Control Consortium (INICC), Part II: Impact of a Multidimensional Strategy to Reduce Ventilator-Associated Pneumonia in Neonatal Intensive Care Units in 10 Developing Countries

    Article • Infection Control, July 2012, Cambridge University Press

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  234. Findings of the International Nosocomial Infection Control Consortium (INICC), Part I: Effectiveness of a Multidimensional Infection Control Approach on Catheter-Associated Urinary Tract Infection Rates in Pediatric Intensive Care Units of 6 Developing...

    Article • Infection Control, July 2012, Cambridge University Press

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  235. Impact of a multidimensional infection control strategy on catheter-associated urinary tract infection rates in the adult intensive care units of 15 developing countries: findings of the International Nosocomial Infection Control Consortium (INICC)

    Article • Infection, June 2012, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Souha Kanj

  236. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009

    Article • American Journal of Infection Control, June 2012, Elsevier

    Dr Gabriel Arteaga-Troncoso, Professor Hakan Leblebicioglu, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Souha Kanj

  237. Características demográficas, morbilidad y mortalidad de los pacientes adultos con neutropenia febril tratados con cefepima

    Article • Revista chilena de infectología, June 2012, SciELO Comision Nacional de Investigacion Cientifica Y Tecnologica (CONICYT)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  238. Effects of Oral Bisphosphonate Therapy on Serum Calcium in Elderly Veterans With Poor Kidney Function

    Article • The American Journal of Geriatric Pharmacotherapy, June 2012, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  239. Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study

    Article • BMC Infectious Diseases, April 2012, Springer Science + Business Media

    Ronald Hall, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  240. Ranolazine for the treatment of refractory angina in a veterans population

    Article • Cardiovascular Revascularization Medicine, March 2012, Elsevier

    Dr Krystal L Edwards, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  241. Uso prudente de antimicrobianos basado en el Plan Obligatorio de Salud

    Article • Infectio, March 2012, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  242. The emergence of multidrug-resistant Acinetobacter baumannii in Colombia: a time-series analysis, 2001-2007

    Article • Revista de Salud Pública, August 2011, FapUNIFESP (SciELO)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  243. Diagnóstico de micosis oportunistas en pacientes con VIH/sida: un estudio de casos en Colombia

    Article • Infectio, June 2011, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  244. Consenso de uso de antimicrobianos en pacientes críticamente enfermos con falla renal o en riesgo de padecerla

    Article • Infectio, March 2011, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  245. Bacteriemia por Staphylococcus aureus resistente a la meticilina en la unidad de cuidados intensivos: revisión de los estudios de pronóstico

    Article • Infectio, March 2011, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  246. Detección de hipotiroidismo en un programa de atención de VIH/SIDA en un hospital de Bogotá, Colombia

    Article • Revista chilena de infectología, February 2011, SciELO Comision Nacional de Investigacion Cientifica Y Tecnologica (CONICYT)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  247. Impact of International Nosocomial Infection Control Consortium (INICC) Strategy on Central Line–Associated Bloodstream Infection Rates in the Intensive Care Units of 15 Developing Countries

    Article • Infection Control, December 2010, Cambridge University Press

    Professor Hakan Leblebicioglu, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Souha Kanj

  248. Guías de práctica clínica para la prevención de infecciones intrahospitalarias asociadas al uso de dispositivos médicos

    Article • Infectio, December 2010, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  249. La prevención de las infecciones asociadas a la atención en salud: un reto en el mejoramiento de la seguridad del paciente

    Article • Infectio, December 2010, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  250. Prevention strategies for methicillin-resistant Staphylococcus aureus (MRSA) in Latin America

    Article • The Brazilian Journal of Infectious Diseases, December 2010, FapUNIFESP (SciELO)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  251. Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America

    Article • International Journal of Infectious Diseases, July 2010, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  252. Resistencia bacteriana, transmisión cruzada y control de la infección asociada a la atención en salud

    Article • Infectio, June 2010, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  253. Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America

    Article • The Brazilian Journal of Infectious Diseases, June 2010, FapUNIFESP (SciELO)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  254. Nosocomial infections caused by community-associated methicillin-resistant Staphylococcus aureus in Colombia

    Article • American Journal of Infection Control, May 2010, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  255. Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America

    Article • The Brazilian Journal of Infectious Diseases, May 2010, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  256. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART

    Article • The Brazilian Journal of Infectious Diseases, April 2010, FapUNIFESP (SciELO)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  257. Differences in DeterminingIn VitroTigecycline Susceptibility According to the Agar Medium Used

    Article • Journal of Chemotherapy, April 2010, Taylor & Francis

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  258. Central line associated bloodstream infection rates in 166 intensive care units of 54 cities in 23 developing countries: findings of the International Nosocomial Infection Control Consortium (INICC)

    Article • International Journal of Infectious Diseases, March 2010, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  259. Changes in macrophage membrane properties during early Leishmania amazonensis infection differ from those observed during established infection and are partially explained by phagocytosis

    Article • Experimental Parasitology, March 2010, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  260. Comparison between three not pharmacological strategies aimed to prevent the dissemination of the A/H1N1 influenza virus in Colombia

    Article • International Journal of Infectious Diseases, March 2010, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  261. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART

    Article • The Brazilian Journal of Infectious Diseases, March 2010, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  262. Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

    Article • The Lancet, January 2010, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  263. Neumonía necrosante por Staphylococcus aureus extrahospitalario resistente a la meticilina:reporte de dos casos en Colombia

    Article • Biomédica, December 2009, Instituto Nacional de Salud

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  264. Xantelasma gástrico sobre pólipo hiperplásico

    Article • Gastroenterología y Hepatología, November 2009, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  265. Epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in Latin America

    Article • International Journal of Antimicrobial Agents, October 2009, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  266. Transmisión de enfermedades en los vuelos comerciales: del mito a la realidad

    Article • Infectio, September 2009, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  267. Comprometidos con el conocimiento y el control de las infecciones

    Article • Infectio, June 2009, Asociacion Colombiana de Infectologia - ACIN

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  268. Combination thiazolidinedione and fibrate effect on high-density lipoprotein cholesterol (HDL-C) concentration in a Veterans Affairs patient population

    Article • Journal of Clinical Lipidology, December 2008, Elsevier

    Dr Krystal L Edwards, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  269. Validación de Índices Pronósticos e Infección del Sitio Quirúrgico en Hospitales de Colombia

    Article • Revista de Salud Pública, December 2008, FapUNIFESP (SciELO)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  270. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008

    Article • American Journal of Infection Control, November 2008, Elsevier

    Professor Hakan Leblebicioglu, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno, Souha Kanj

  271. Identification of Secreted Proteins that Mediate Cell-Cell Interactions in an In vitro Model of the Lung Cancer Microenvironment

    Article • Cancer Research, August 2008, American Association for Cancer Research (AACR)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  272. Third-Line Agent Selection for Patients with Type 2 Diabetes Mellitus Uncontrolled with Sulfonylureas and Metformin

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, April 2008, Wiley

    Dr Krystal L Edwards, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  273. Haga usted el diagnóstico. Primera parte

    Article • Biomédica, August 2007, Instituto Nacional de Salud

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  274. Haga usted el diagnóstico. Segunda parte

    Article • Biomédica, August 2007, Instituto Nacional de Salud

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  275. Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis

    Article • Journal of Infection, July 2007, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  276. Malaria in a Liver Transplant Recipient: A Case Report

    Article • Transplantation Proceedings, November 2006, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  277. Device-Associated Nosocomial Infections in 55 Intensive Care Units of 8 Developing Countries

    Article • Annals of Internal Medicine, October 2006, American College of Physicians

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  278. Extra Length of Stay of Nosocomial Infections in Pediatric ICUs of Colombia and Mexico. Findings of the International Nosocomial Infection Control Consortium (INICC)

    Article • American Journal of Infection Control, June 2006, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  279. Resistencia Antimicrobiana en Unidades de Cuidado Intensivo de Bogotá, Colombia, 2001-2003

    Article • Revista de Salud Pública, May 2006, FapUNIFESP (SciELO)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  280. Canales Endémicos y Marcadores de Resistencia Bacteriana, en Instituciones de Tercer nivel de Bogota, Colombia

    Article • Revista de Salud Pública, May 2006, FapUNIFESP (SciELO)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  281. Device-Associated Infection Rate and Mortality in Intensive Care Units of 9 Colombian Hospitals: Findings of the International Nosocomial Infection Control Consortium

    Article • Infection Control, April 2006, Cambridge University Press

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  282. Community-associated Methicillin-resistantStaphylococcus aureus, Colombia

    Article • January 2006, Centers for Disease Control and Prevention (CDC)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  283. AIDS in the Intensive Care Unit

    Article • January 2004, Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  284. Application of natural gamma radiometric equipment in an underground mine in Spain

    Article • International Journal of Mineral Processing, May 2002, Elsevier

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  285. Comparación de dos pruebas de aglutinación (Toxolatex ® y Toxoscreen ®) en el diagnóstico de la toxoplasmosis: propuesta de inclusión en un programa de control

    Article • Biomédica, June 2000, Instituto Nacional de Salud

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  286. Prevalence of Trypanosoma cruzi and Leishmania chagasi infection and risk factors in a Colombian indigenous population

    Article • Revista do Instituto de Medicina Tropical de São Paulo, July 1999, FapUNIFESP (SciELO)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  287. Lagochilascaris minor IN A PATIENT FROM THE COLOMBIAN AMAZON: A CASE REPORT

    Article • Revista do Instituto de Medicina Tropical de São Paulo, November 1998, FapUNIFESP (SciELO)

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  288. Current status of onchocerciasis in Colombia.

    Article • American Journal of Tropical Medicine and Hygiene, May 1998, American Society of Tropical Medicine and Hygiene

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  289. Dissemination Control of the Antimicrobial Resistance in the Intensive Care Unit

    Article • Springer Science + Business Media

    M.D; Ph.D; FIDSA Carlos Alvarez-Moreno